– USA, IL – AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, and consumer product dispensing, today announced the appointment of Julie Xing to its Board of Directors.
“We look forward to welcoming Julie to our highly talented, diverse and multi-cultural Board of Directors. With 45% of our Board consisting of women and 27% of our Board comprised of persons of color, we are proud to be a leading company for greater diversity and gender equality on corporate boards,” said Board Chairman, George Fotiades.
About Julie Xing
With over 20 years of experience in the pharmaceutical, medtech, digital health, biotech, and diagnosis, her leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. With her solid track record of business transformation in multiple global positions, Julie is recognized as a highly engaging multicultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
Since 2022, Julie has served as Executive Chair of the Board of Directors of Mundipharma China. Mundipharma is a global pharmaceutical leader. Before that, Julie held the position of Global SVP, President of Greater China for Envista Holdings Corporation. Julie’s breadth of experience also includes numerous leadership roles at Eli Lilly and Company, including Senior Director, Global New Product Planning and Payer Marketing, Pricing, Reimbursement and Access of Lilly Diabetics and VP, Corporate and Government Affairs and Market Access and VP of Lilly China Oncology, while based in Shanghai. Before Eli Lilly, Julie was VP and General Manager of Asia Pacific and Japan Operations at Panomics and Affymetrix, which was acquired by Thermo Fisher Scientific.
In addition, she has served as Board Advisor on the Board of Directors for Mars, a global manufacturer of confectionery, pet food, and provider of animal care services, since 2019.
Julie Xing said, “Aptar is an industry leader with a deep portfolio of products and services that spans many different and attractive pharmaceutical and consumer end markets. I am excited to join Aptar’s Board of Directors to build upon the Company’s more than 75-year history of developing innovative products that millions of people around the world use every day.”
Julie holds a Ph.D. in Biology from the Hong Kong University of Science and Technology.
About Aptar
Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing, and active material science solutions and services. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, food, personal care, home care, and beverage. Using insights, proprietary design, engineering, and science to create dispensing, dosing, and protective technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health, and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois, and has 13,500 dedicated employees in 20 countries.
For more information: https://www.aptar.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
